Fountain Therapeutics

Fountain Therapeutics is a biopharmaceutical company dedicated to identifying and developing therapeutics that treat the underlying causes of aging. The company utilizes an AI-driven platform that leverages computer vision and machine learning to analyze cellular morphology, allowing for the identification of compounds that can reverse the aging process at a cellular level. By screening vast libraries of small molecules against aged cells, Fountain aims to discover novel targets and treatments for chronic inflammatory, metabolic, and neurodegenerative conditions. Their approach shifts the paradigm from managing symptoms of age-related diseases to fundamentally rejuvenating cellular health. The company was founded on the research of Dr. Thomas Rando and is backed by prominent investors including Khosla Ventures and SoftBank.